Emergence of blockbuster-level obesity drug, but Furing and Xenical decrease narrowly

It was the year that the market has shown enormous interests on newly-launched obesity treatments after a long time.

Belviq, which acquired FDA’s approval in 13 years, has suddenly became a leading product as introduced by Ildong Pharm since the last March.

The emergence of Belviq was transferred to the interests of the entire obesity treatment market, which led upturns of the existing drugs ...